Global Human Insulin Market to Reach $79.1 Billion by 2030
The global market for Human Insulin estimated at US$50.1 Billion in the year 2023, is expected to reach US$79.1 Billion by 2030, growing at a CAGR of 6.7% over the period 2023-2030. HI Drugs, one of the segments analyzed in the report, is expected to record 6.6% CAGR and reach US$70.6 Billion by the end of the analysis period. Growth in the HI Delivery Devices segment is estimated at 7.6% CAGR for the next 7-year period.
The U.S. Market is Estimated at $13.2 Billion, While China is Forecast to Grow at 10.2% CAGR
The Human Insulin market in the U.S. is estimated at US$13.2 Billion in the year 2023. China, the world`s second largest economy, is forecast to reach a projected market size of US$18.9 Billion by the year 2030 trailing a CAGR of 10.2% over the analysis period 2023 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 3.5% and 6% respectively over the 2023-2030 period. Within Europe, Germany is forecast to grow at approximately 4% CAGR.
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook